Skip to main content
. 2016 Apr 6;127(21):2536–2545. doi: 10.1182/blood-2016-01-678128

Figure 2.

Figure 2

Reversal of hemoglobin switching to induce therapeutic levels of HbF. Reversal of hemoglobin switching can be accomplished through autologous bone marrow transplantation of genome-edited CD34+ HSPCs. The gray region indicates the hypothesized levels of HbF required for clinical benefit.